Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop
Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop
About this item
Full title
Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop
Author / Creator
Publisher
England
Journal title
Nicotine & tobacco research, 2019-01, Vol.21 (1), p.3-13
Language
English
Formats
Publication information
Publisher
England
Subjects
More information
Scope and Contents
Contents
Since 2009, the United States (US) Food and Drug Administration (FDA) Center for Tobacco Products (CTP) has had the authority to regulate the manufacture, distribution, and marketing of tobacco products in order to reduce the death and disease caused by tobacco use. Biomarkers could play an important role across a number of FDA regulatory activitie...
Alternative Titles
Full title
Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1978716416
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1978716416
Other Identifiers
ISSN
1469-994X
E-ISSN
1469-994X
DOI
10.1093/ntr/ntx273
